IMRT

Final Remarks

SBRT is currently widely accepted as the best alternative to surgery for early stage lung cancer SBRT is feasible with various technical solutions, apparently without any difference in outcomes Mature data on long-term follow up are needed to better understand the pattern of relapse Predictive and prognostic factors are needed to better select patients at higher risk of progression for possible adjuvant therapies

03/01/13